AU5959900A - Oligonucleotides for metabotropic glutamate receptor type 1 (mglur1) - Google Patents
Oligonucleotides for metabotropic glutamate receptor type 1 (mglur1)Info
- Publication number
- AU5959900A AU5959900A AU59599/00A AU5959900A AU5959900A AU 5959900 A AU5959900 A AU 5959900A AU 59599/00 A AU59599/00 A AU 59599/00A AU 5959900 A AU5959900 A AU 5959900A AU 5959900 A AU5959900 A AU 5959900A
- Authority
- AU
- Australia
- Prior art keywords
- mglur1
- oligonucleotides
- receptor type
- glutamate receptor
- metabotropic glutamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3511—Conjugate intercalating or cleaving agent
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14400499P | 1999-07-15 | 1999-07-15 | |
US60/144004 | 1999-07-15 | ||
PCT/CA2000/000824 WO2001005963A2 (en) | 1999-07-15 | 2000-07-17 | ANTISENSE OLIGONUCLEOTIDES FOR METABOTROPIC GLUTAMATE RECEPTOR TYPE 1 (mGluR1) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5959900A true AU5959900A (en) | 2001-02-05 |
Family
ID=22506645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU59599/00A Abandoned AU5959900A (en) | 1999-07-15 | 2000-07-17 | Oligonucleotides for metabotropic glutamate receptor type 1 (mglur1) |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1238069A2 (en) |
AU (1) | AU5959900A (en) |
CA (1) | CA2377937A1 (en) |
WO (1) | WO2001005963A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395289B1 (en) * | 2001-06-07 | 2010-12-15 | Christine Dr. Sang | Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
WO2005075987A2 (en) * | 2004-01-28 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 1 (mglur1) |
EP1789553B1 (en) | 2004-06-30 | 2014-03-26 | Alnylam Pharmaceuticals Inc. | Oligonucleotides comprising a non-phosphate backbone linkage |
EP2567696A1 (en) | 2006-11-22 | 2013-03-13 | Seaside Therapeutics, Inc. | Compositions for treating autism spectrum disorder |
EP2544688B1 (en) | 2010-03-02 | 2016-09-07 | President and Fellows of Harvard College | Methods and compositions for treatment of angelman syndrome |
US20110294879A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
WO2012009646A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
WO2012054724A1 (en) | 2010-10-21 | 2012-04-26 | Massachusetts Institute Of Technology | Methods of treating seizure disorders |
US11447775B2 (en) | 2018-01-12 | 2022-09-20 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
-
2000
- 2000-07-17 EP EP00945507A patent/EP1238069A2/en not_active Withdrawn
- 2000-07-17 CA CA002377937A patent/CA2377937A1/en not_active Abandoned
- 2000-07-17 AU AU59599/00A patent/AU5959900A/en not_active Abandoned
- 2000-07-17 WO PCT/CA2000/000824 patent/WO2001005963A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2377937A1 (en) | 2001-01-25 |
EP1238069A2 (en) | 2002-09-11 |
WO2001005963A3 (en) | 2001-11-08 |
WO2001005963A2 (en) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4797400A (en) | Metabotropic glutamate receptor antagonists | |
AU6775700A (en) | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors | |
AU4802500A (en) | 2-aminoquinolinecarboxamides: neurokinin receptor ligands | |
AU2903701A (en) | Olfactory receptor sequences | |
IL136250A0 (en) | Metabotropic glutamate receptor antagonist compounds | |
AU2432099A (en) | Phenylalanine derivatives useful as pharmaceutical agents | |
AU3265101A (en) | Software based stamp dispenser | |
AU3783497A (en) | Metabotropic glutamate receptor agonists | |
AU5206099A (en) | Spreader bar apparatus | |
AU5095000A (en) | Receptor interacting protein rip3 | |
AU2001248849A1 (en) | Estra-1,3,5(10)-triene derivatives | |
AU3819200A (en) | 2,4-diamino-pyrimidine derivatives | |
AU1229801A (en) | A novel human metabotropic glutamate receptor | |
AU5959900A (en) | Oligonucleotides for metabotropic glutamate receptor type 1 (mglur1) | |
AU1054900A (en) | Compositions comprising notch receptor manipulating agents | |
AU3468599A (en) | Gaba b receptor | |
AU5568400A (en) | Novel dihydropyrimidine derivatives | |
IL136500A0 (en) | 1,4-diazacycloheptane derivatives | |
AU5787201A (en) | Compounds active at the glucocorticoid receptor | |
AUPP279698A0 (en) | Sustained release formulation | |
AU5801099A (en) | 14926 receptor, a novel g-protein coupled receptor | |
AU5569098A (en) | 2,4-diaminopyrimidine compounds as anti-cancer agents | |
AU2001223882A1 (en) | Receptor | |
AUPQ563400A0 (en) | Novel receptor | |
AU5753399A (en) | Self raising hopper for delivering aggregate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |